Larvol Delta - New-Phase-1-Dose-Escalation-Cohorts-Data-for-Aulos-Biosciences-AU007-Show-Favorable-Pharmacodynamic-Effects-at-2023-AACRNCIEORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics

AU-007 - Aulos Biosci

https://www.businesswire.com/news/home/20231014994103/en/New-Phase-1-Dose-Escalation-Cohorts-Data-for-Aulos-Bioscience%E2%80%99s-AU-007-Show-Favorable-Pharmacodynamic-Effects-at-2023-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics

Oct 14, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next